Point-of-care biomarker quantification enabled by sample-specific calibration
Citations Over TimeTop 10% of 2019 papers
Abstract
Easy-to-perform, relatively inexpensive blood diagnostics have transformed at-home healthcare for some patients, but they require analytical equipment and are not easily adapted to measuring other biomarkers. The requirement for reliable quantification in complex sample types (such as blood) has been a critical roadblock in developing and deploying inexpensive, minimal-equipment diagnostics. Here, we developed a platform for inexpensive, easy-to-use diagnostics that uses cell-free expression to generate colored readouts that are visible to the naked eye, yet quantitative and robust to the interference effects seen in complex samples. We achieved this via a parallelized calibration scheme that uses the patient sample to generate custom reference curves. We used this approach to quantify a clinically relevant micronutrient and to quantify nucleic acids, demonstrating a generalizable platform for low-cost quantitative diagnostics.
Related Papers
- → Resonance Raman spectroscopic evaluation of skin carotenoids as a biomarker of carotenoid status for human studies(2013)110 cited
- → Supporting evidence for using biomarkers in the diagnosis of MCI due to AD(2012)55 cited
- → P2‐215: Supporting evidence of the Alzheimer's disease biomarker dynamic model in patients with mild cognitive impairment(2012)1 cited
- → P.1.c.001 An ethopharmacological assessment of the effects of (R, S)-2-chloro-5-hydroxyphenylglycine (CHPG) on agonistic interactions in male mice(2008)
- → P4‐123: Resolving Conflicting CSF Biomarker Information in Alzheimer′s Disease(2016)